Investors are always looking for stocks that are poised to beat at earnings season and Johnson & Johnson JNJ may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because Johnson & Johnson is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for JNJ in this report.In fact, the Most Accurate Estimate for the current quarter is currently at $2.48 per share for JNJ, compared to a broader Zacks Consensus Estimate of $2.42 per share. This suggests that analysts have very recently bumped up their estimates for JNJ, giving the stock a Zacks Earnings ESP of +2.54% heading into earnings season.Johnson & Johnson Price and EPS Surprise Johnson & Johnson price-eps-surprise | Johnson & Johnson QuoteWhy is this Important?A positive reading for the Zacks Earnings ESP has proven to be very powerful in producing both positive surprises, and outperforming the market. Our recent 10-year backtest shows that stocks that have a positive Earnings ESP and a Zacks Rank #3 (Hold) or better show a positive surprise nearly 70% of the time, and have returned over 28% on average in annual returns (see more Top Earnings ESP stocks here).Given that JNJ has a Zacks Rank #3 and an ESP in positive territory, investors might want to consider this stock ahead of earnings. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Clearly, recent earnings estimate revisions suggest that good things are ahead for Johnson & Johnson, and that a beat might be in the cards for the upcoming report. The Hottest Tech Mega-Trend of All Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.See Zacks' 3 Best Stocks to Play This Trend >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Johnson & Johnson (JNJ): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research